Sol-Gel Technologies Ltd.
NASDAQ:SLGLBiotechnology
+$1.19 today
- Market cap
- $174.70M
- Beta
- 1.13
- P/E (TTM)
- -194.1
- EPS (TTM)
- -$0.37
Volume 0.03M
Average 0.04M
SLGL Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Sol-Gel Technologies Ltd.NASDAQ: SLGL
Operating Expenses · Q1 FY2026 · quarter ended Mar 2026
Operating expenses declines year over year
Q1 FY2026 operating expenses of $3.96M fell 60.8% year over year, behind the -21.5% change in trailing-twelve-month operating expenses. Sequentially, it fell 3.5% from the prior quarter. Over 3 fiscal years it compounded at +53.5% a year.
Context
- Operating expenses amounted to 138.9% of revenue in FY2025, down 63.2 pp from a year earlier.
- Operating expenses increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -60.8% toward the trailing-twelve-month pace of -21.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 26.93M USD
- Year-over-year change
- +15.5%
- 4-year CAGR
- +35.8%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 26.93M | +15.5% |
| FY2024 | 2024-12-31 | 23.32M | +218.7% |
| FY2023 | 2023-12-31 | 7.32M | -1.7% |
| FY2022 | 2022-12-31 | 7.45M | -6.1% |
| FY2021 | 2021-12-31 | 7.93M | — |
Operating Expenses vs competitors
How SLGL compares with its peers on the latest reported figures
- SLGL's LTM Mar 2026 operating expenses of $20.79M is the 7th highest of the 10 companies compared; the peer median is $29.92M.
- Its year-over-year change of -21.5% is the 6th highest of 10, against a peer median of -10.6%.
- Operating expenses amounts to 112.6% of revenue for SLGL, versus a peer median of 573.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $173.51M | -10.6% | -12.1% | 110.5% | |
| LTM Mar 2026 | $144.89M | -39.4% | -12.4% | — | |
| LTM Mar 2026 | $118.5M | -49.4% | +2.7% | — | |
| LTM Mar 2026 | $54.82M | -4.8% | -4.7% | 769.8% | |
| LTM Mar 2026 | $29.92M | +225.6% | +73.5% | 376.8% | |
| FY2025 | $21.05M | +33.3% | +5.5% | — | |
| LTM Mar 2026 | $20.79M | -21.5% | +53.5% | 112.6% | |
| LTM Mar 2026 | $20.57M | -27.1% | -21.9% | 15353.0% | |
| LTM Mar 2026 | $14.22M | -0.8% | -29.6% | — | |
| FY2025 | $7.19M | -54.2% | +4.9% | — | |
| Peer median (excluding SLGL) | $29.92M | -10.6% | -4.7% | 573.3% | |
Competitors are the stored peer set for SLGL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 31.27M | 3.88M | 1.55M | 11.54M | 19.39M |
| Cost of Revenue | 20.38M | 12.68M | 342K | 233K | 109K |
| Gross Profit | 10.89M | (8.8M) | (21.99M) | 11.31M | 19.39M |
| Gross Margin | 34.8% | -226.6% | -1414.9% | 98.0% | 100.0% |
| Research & Development | 20.38M | 12.68M | 23.54M | 17.8M | 22.8M |
| Selling, General & Admin | 8.45M | 7.45M | 7.37M | 5.75M | 4.18M |
| Operating Expenses | 7.93M | 7.45M | 7.32M | 23.32M | 26.93M |
| Depreciation & Amortization | 880K | 562K | 342K | 233K | 109K |
| EBITDA | 3.84M | (15.68M) | (28.96M) | (10.35M) | (7.43M) |
| EBITDA Margin | 12.3% | -403.9% | -1863.8% | -89.7% | -38.3% |
| Operating Income | 2.96M | (16.24M) | (29.31M) | (12.01M) | (7.54M) |
| Operating Margin | 9.5% | -418.3% | -1885.8% | -104.1% | -38.9% |
| Interest Income | 257K | 1.32M | 2.07M | 1.43M | 1.41M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 257K | 1.32M | 2.07M | 1.43M | 1.41M |
| Income Before Tax | 3.22M | (14.92M) | (27.24M) | (10.58M) | (6.13M) |
| Pre-Tax Margin | 10.3% | -384.3% | -1752.8% | -91.7% | -31.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | 3.22M | (14.92M) | (27.24M) | (10.58M) | (6.13M) |
| Net Margin | 10.3% | -384.3% | -1752.8% | -91.7% | -31.6% |
| EPS (Basic) | 1.40 | (0.65) | (1.01) | (0.38) | (2.20) |
| EPS (Diluted) | 0.14 | (0.65) | (1.01) | (0.38) | (2.20) |
| Weighted Avg Shares | 23.06M | 23.13M | 27.09M | 27.86M | 2.79M |
| Weighted Avg Shares (Diluted) | 23.57M | 23.13M | 27.09M | 27.86M | 2.79M |
Sol-Gel Technologies Ltd.
NASDAQ:SLGL
Intrinsic Alpha fair value
Locked
Current Price
$53.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.